久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

US EUROPE AFRICA ASIA 中文
Business / Companies

Guilin at forefront in battle against malaria

By Wang Hongyi (China Daily) Updated: 2015-11-09 09:47

Since 2000, global mortality rates among malaria patients have dropped by 47 percent. In Africa, the rate has come down by 54 percent for adults and 58 percent for children.

GPSC has played an important role, along with major global pharmaceutical companies such as Novartis in Switzerland and Sanofi-Aventis in France, in fighting malaria.

The Chinese company was at the forefront in developing the innovative artesunate vaccine, Artsun, the first of its kind, to replace quinine injections. The WHO has compared it to the "gold standard" in the battle against malaria.

Artsun is now registered in more than 30 countries and regions and has a 90 percent market share in treating servere malaria.

During the past three years, GPSC has supplied 23.8 million units of the vaccine globally, saving more than 3.4 million people from the scourge of malaria.

"This is an innovative drug that was developed in China," Guo Guangchang, chairman of Fosun Group, said.

During the past decade, 13 anti-malaria drugs developed by GPSC have been approved by the WHO, including three which are injected and 10 in oral tablets.

The company's products account for 80 percent of China's anti-malaria drug exports.

In the first three quarters of this year, Fosun Pharmaceutical, which includes GPSC, reported revenue of 9 billion yuan ($1.41 billion), a rise of 4.76 percent compared to the same period in 2014.

Further financial details have yet to be released. The company's products include metabolism and digestive system drugs, and vaccines, as well as GPSC's brands.

"At present, Guilin Pharma is building a new manufacturing site which will comply with (international) standards," GPSC said.

"In future, we will have a production capacity of over 15 billion tablets/capsules per year to meet the needs of both domestic and global markets." the company added.

Fosun Pharmaceutical also plans to expand its research and development program by working alongside institutions and other organizations.

"There should be more cooperation with research institutes and organizations," Chen Qiyu, chairman of Fosun Pharmaceutical, said.

"This would help create a much larger platform, allowing us to do a better job globally."

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 中文字幕在线观看不卡视频 | 国产人成精品 | 日韩欧美在线观看一区 | 麻豆69堂免费视频 | 国产高清视频免费最新在线 | 国产高清国产专区国产精品 | 中文字幕国产一区 | 亚洲精品成人久久 | 欧美一级aa毛片禁片 | 96精品视频在线播放免费观看 | 宅男毛片| 日本免费成人网 | 亚洲欧美一区二区三区在线观看 | 国产精品人伦久久 | 国产精品美女一级在线观看 | 嫩草一区二区三区四区乱码 | 欧美一区在线观看视频 | 免费一级毛片在线播放放视频 | 欧洲97色综合成人网 | 欧美一二三 | 成人久久久久 | 日韩毛片基地 | 免费人成年短视频在线观看免费网站 | 亚洲男人在线天堂 | 欧美大尺度免费一级特黄 | 国产午夜亚洲精品一区网站 | 一级一片在线播放在线观看 | 国产短裙黑色丝袜在线观看下 | 免费一区二区三区四区 | 久久国产精品久久久久久 | 黄色三级日韩 | 韩国一级片在线观看 | 中文字幕在线播 | 国产精品视频九九九 | 黄色网址在线免费观看 | 久久91精品国产91久久小草 | 亚洲视频播放 | 久草亚洲视频 | a毛片免费观看 | 亚洲欧美激情视频 | 亚洲欧美在线观看视频 |